Exjade and Yellow skin - a phase IV clinical study of FDA data
Summary:
Yellow skin is reported as a side effect among people who take Exjade (deferasirox), especially for people who are female, 30-39 old, have been taking the drug for 1 - 6 months also take Hydrea, and have Iron metabolism disorder.
The phase IV clinical study analyzes which people have Yellow skin when taking Exjade. It is created by eHealthMe based on reports of 29,418 people who have side effects when taking Exjade from the FDA, and is updated regularly.
What is Exjade?
Exjade has active ingredients of deferasirox. It is often used in iron overload. eHealthMe is studying from 29,456 Exjade users. Check the latest studies of Exjade.
What is Yellow skin?
Yellow skin is found to be associated with 425 drugs and 1,105 conditions by eHealthMe. Check the latest studies of Yellow skin.
29,418 people reported to have side effects when taking Exjade.
Among them, 54 people (0.18%) have Yellow skin.
Among these 54 people:
How long have people been on Exjade when they have Yellow skin? *
- < 1 month: 0.0 %
- 1 - 6 months: 46.15 %
- 6 - 12 months: 15.38 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 38.46 %
- 10+ years: 0.0 %
What is the gender of people who have Yellow skin when taking Exjade? *
- female: 53.85 %
- male: 46.15 %
What is the age of people who have Yellow skin when taking Exjade? *
- 0-1: 0.0 %
- 2-9: 18.18 %
- 10-19: 9.09 %
- 20-29: 18.18 %
- 30-39: 39.39 %
- 40-49: 0.0 %
- 50-59: 3.03 %
- 60+: 12.12 %
What are other drugs people take besides Exjade? *
- Hydrea: 9 people, 16.67%
- Jadenu: 6 people, 11.11%
- Folic Acid: 4 people, 7.41%
- Desferal: 3 people, 5.56%
- Fluoxetine: 3 people, 5.56%
- Aspirin: 3 people, 5.56%
- Asa: 2 people, 3.70%
- Cardizem Cd: 2 people, 3.70%
- Glimepiride: 2 people, 3.70%
- Januvia: 2 people, 3.70%
What are other side effects people have besides Yellow skin? *
- Haemoglobin Decreased: 21 people, 38.89%
- Serum Ferritin Increased: 18 people, 33.33%
- Malaise (a feeling of general discomfort or uneasiness): 18 people, 33.33%
- Fever: 18 people, 33.33%
- Fatigue (feeling of tiredness): 17 people, 31.48%
- Nausea And Vomiting: 17 people, 31.48%
- Pain: 17 people, 31.48%
- Diarrhea: 16 people, 29.63%
- Abdominal Pain: 15 people, 27.78%
- Renal Disorder (kidney disease): 14 people, 25.93%
What are the existing conditions these people have? *
- Anaemia (lack of blood): 5 people, 9.26%
- Iron Metabolism Disorder: 5 people, 9.26%
- Aplastic Anemia: 4 people, 7.41%
- Bone Marrow Failure: 3 people, 5.56%
- Primary Myelofibrosis (primary disorder of the bone marrow): 3 people, 5.56%
- Haemochromatosis (body to absorb more iron than usual from food): 2 people, 3.70%
- Immunodeficiency: 2 people, 3.70%
- Pain: 2 people, 3.70%
- High Blood Pressure: 2 people, 3.70%
- Paroxysmal Nocturnal Haemoglobinuria (haemoglobin in the urine): 2 people, 3.70%
* Approximation only. Some reports may have incomplete information.
Do you take Exjade and have Yellow skin?
- Check whether Yellow skin is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Exjade:
- Exjade (29,456 reports)
Yellow skin treatments and more:
- Yellow skin (5,858 reports)
How severe was Yellow skin and when was it recovered:
Expand to all the drugs that have ingredients of deferasirox:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Exjade:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Yellow skin:
- Yellow skin (425 drugs)
Browse all the conditions that are associated with Yellow skin:
- Yellow skin (1,105 conditions)
Related publications that referenced our studies
- Díaz-García JD, Gallegos-Villalobos A, Gonzalez-Espinoza L, Sanchez-Ni?o MD, Villarrubia J, Ortiz A, "Deferasirox nephrotoxicity [mdash] the knowns and unknowns", Nature reviews nephrology, 2014 Oct .
- Riva A, "Comment on: A record number of fatalities in many categories of patients treated with deferasirox: loopholes in regulatory and marketing procedures undermine patient safety and misguide public funds?", Expert opinion on drug safety, 2013 Sep .
- Riva A, "Deferasirox's toxicity", The Lancet, 2013 Jul .
- Kontoghiorghes GJ, "Turning a blind eye to deferasirox's toxicity?", The Lancet, 2013 Apr .
- Kontoghiorghes GJ, "A record number of fatalities in many categories of patients treated with deferasirox: loopholes in regulatory and marketing procedures undermine patient safety and misguide public funds?", Taylor & Francis, 2013 Jan .
- Díaz-García JD, Gallegos-Villalobos A, Gonzalez-Espinoza L, Sanchez-Ni?o MD, Villarrubia J, Ortiz A, "Deferasirox nephrotoxicity [mdash] the knowns and unknowns", Nature reviews nephrology, 2014 Oct .
- Riva A, "Comment on: A record number of fatalities in many categories of patients treated with deferasirox: loopholes in regulatory and marketing procedures undermine patient safety and misguide public funds?", Expert opinion on drug safety, 2013 Sep .
- Riva A, "Deferasirox's toxicity", The Lancet, 2013 Jul .
- Kontoghiorghes GJ, "Turning a blind eye to deferasirox's toxicity?", The Lancet, 2013 Apr .
- Kontoghiorghes GJ, "A record number of fatalities in many categories of patients treated with deferasirox: loopholes in regulatory and marketing procedures undermine patient safety and misguide public funds?", Taylor & Francis, 2013 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on deferasirox (the active ingredients of Exjade) and Exjade (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Xywav cause Psoriatic Arthropathy? - a second ago
- Drug interactions of Dutasteride and Vitamin E - 4 seconds ago
- Could Lamotrigine cause Blood Creatine Increased? - 15 seconds ago
- Drug interactions of Excedrin and Sudafed - 17 seconds ago
- Could Sennosides cause Erection Problems? - 18 seconds ago
- Drug interactions of Estradiol and Lantus - 27 seconds ago
- Drug interactions of Sudafed 12 Hour and Prandin - 35 seconds ago
- Drug interactions of Canagliflozin and Zide - 36 seconds ago
- Drug interactions of Rocephin and Lovenox - 38 seconds ago
- Could Novolog cause Urethral Stenosis? - 41 seconds ago